The prognostic impact of CDKN2A homozygous deletion in diffuse IDH-mutant astrocytomas is still under debate in the literature [9] for grade 4 subsets, but not for grades 2 and 3 [10]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).